Public Defence: Endovascular Treatment of Complex Aortic Pathologies: The Importance of Adequate Patient Selection and Thorough Evaluation of Novel Techniques
- Date:
- Location: Akademiska sjukhuset H:son Holmdahlsalen, ing 100, bv
- Doctoral student: Carlota Fernandez Prendes PhD student at Department of Surgical Sciences, Vascular Surgery
- Contact person: Kevin Mani
- Disputation
Carlota Fernandez Prendes defends his thesis "Endovascular Treatment of Complex Aortic Pathologies: The Importance of Adequate Patient Selection and Thorough Evaluation of Novel Techniques".
Abstract [en]
Aortic pathologies include a broad spectrum of diseases, whose inci-dence, prevalence and mortality typically increases with age. Traditional-ly, open surgery was the only viable treatment solution. However, endo-vascular repair has revolutionized aortic treatment, with ever-increasing available devices, more developed techniques, and improved patient outcomes. The combination of an aging population and improving out-comes has led to an ever-increasing number of patients being offered - and ultimately undergoing – treatments, for which 20 years ago they would have been considered too “high-risk”. The past years have also seen significant strides in innovation and technical device feasibility. However, in conjunction with the development of new systems and technologies, an increase in the number of device recalls from the mar-ket has occurred. Is the broadening of patient selection criteria and novel devices really associated with improved outcomes? As these techniques continue to break new boundaries, adequate patient selection and thor-ough assessment of novel technologies becomes only more vital.
The aim of this PhD is therefore to 1) evaluate the effect of age on the outcomes of aortic endovascular treatment; and 2) to expand our knowledge of outcomes following the implementation of novel technolo-gies used for endovascular aortic treatments.
Link to the doctoral thesis in DiVA: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-500192
Events for Medicine and Pharmacy
Subscribe to calendar
Windows
Please follow these instructions to subscribe to the calendar in Outlook on Windows:
- Copy the calendar link.
- Switch to the calendar view in Outlook.
- Right click My calendars (or Other calendars), select Add calendar, select From Internet.
- In the dialogue that pops up, paste the calendar link.
- Approve the subscription.
The calendar is now available in Outlook. Check the checkbox besides the new calendar to view it.
Mac
For Safari on Mac, read these instructions.
Other
In other calendar applications, copy the link and then follow the appropriate procedure.
September 2023
-
–13:00
Biomedicinskt centrum, BMC
Dissertation, Po-Cheng Tang "On antibiotics – biofilm resistance selection and drug interactions"
-
–12:00
Universitetshuset, sal IX
Thesis defence- Studies of the BarnSäkert (SEEK) model – the Swedish Child Health Services as a forum for early identification of psychosocial risk factors in the home environment of young children
-
–11:00
Biomedicinskt centrum, BMC
Genomic seminar, Axel Cederholm "Autoantibodies against type I Interferons"
-
–
Biomedicinskt centrum, BMC
Immunology seminar, Robin Lindsay "What drives changes in T cell motility and function in islets during type 1 diabetes and how can we use this in the future?"
October 2023
-
–14:00
Biomedicinskt centrum, BMC
IMBact seminar, Marie Wrande
-
–14:30
Biomedicinskt centrum, BMC
Post Registration Seminar - Young individuals’ mental health and the importance of health behaviours and lifestyle
-
–16:00
Biomedicinskt centrum, BMC
Special Tumörbiology seminar, Dr. Benoît Ho-Tin-Noé " Platelets in Inflammation and Maintenance of Vascular Integrity"
-
–13:15
Biomedicinskt centrum, BMC
Dissertation, Melanie Herre "Neutrophil extracellular traps as potential therapeutic targets to prevent tumor-induced organ failure and metastasis"
-
–15:00
Biomedicinskt centrum, BMC
Half-time seminar: Self-assembly of therapeutic peptides
Ellen Brunzell, PhD student at the Dep. of Medicinal Chemistry and SweDeliver, presents her work to characterize the structure of self-assembled peptides by using scattering measurements. The early stages of aggregation and effect of solvent additives are investigated. The results from these studies can be used in research of diseases where peptide aggregation plays a major role.
-
–12:00
Rudbecklaboratoriet
Thesis defense Amal Abu Sabaa
Title: Clinical and Molecular Studies of Diffuse Large B-cells Lymphoma